JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB141083

Atorvastatin hemicalcium salt, HMG-CoA reductase inhibitor

Be the first to review this product! Submit a review

|

(0 Publication)

MW 1155.3 Da, Purity >99%. Potent HMG-CoA reductase inhibitor (IC50 = 8 nM). Metabolised by CYP3A4. Able to reduce circulating LDL-C through inhibition of cholesterol biosynthesis and inducing expression of LDL receptors.

View Alternative Names

3 hydroxy 3 methylglutaryl CoA reductase, 3 hydroxymethylglutaryl CoA reductase, 3-hydroxy-3-methylglutaryl CoA reductase (NADPH), 3-hydroxy-3-methylglutaryl-coenzyme A reductase, 3H3M, A830040C14Rik, ABC 31, ABC member 16, MDR/TAP subfamily, ABC16, ABCB1, ABCBB_HUMAN, ABCC 3, AI838772, APOPAIN, ATP binding cassette sub family B (MDR/TAP) member 11, ATP binding cassette sub family C (CFTR/MRP) member 3, ATP-binding cassette sub-family B member 11, ATP-binding cassette sub-family C member 3, AW493413, Apoptotic protease Mch-3, Atherosclerosis, susceptibility to, included, BRIC2, BXR, Bile salt export pump, Bsep, CASP3_HUMAN, CASP7_HUMAN, CC3, CMH-1, CMOAT 2, CPP-32, CPP32B, Canalicular multispecific organic anion transporter 2, Canicular multispecific organic anion transporter, Casp3a, Caspase 3, apoptosis-related cysteine peptidase, Caspase 3, apoptosis-related cysteine protease, Caspase 3, apoptosis-related cysteine protease a, Caspase 7, Caspase 7 apoptosis related cysteine peptidase, Caspase-3, Caspase-3 subunit p12, Caspase-7 subunit p11, Cysteine protease CPP32, DKFZp686N23123, EC 3.4.22.56, ER, ER-alpha, ER-beta, ERR a, ERR-alpha, ERR1 protein, ERR1_HUMAN, ER[a], ER[b], ESR, ESR B, ESR BETA, ESR1_HUMAN, ESRA, ESRL 1, ESRR A, EST90757, ESTR B, Era, Erb, Erb2, Estr, Estra, Estradiol Receptor alpha, Estradiol Receptor beta, Estradiol receptor, Estrogen Receptor 1, Estrogen Receptor 2, Estrogen receptor, Estrogen receptor 1 (alpha), Estrogen receptor 2 (ER beta), Estrogen receptor 2 ER beta, Estrogen receptor alpha, Estrogen receptor beta 4, Estrogen receptor related 1, Estrogen receptor-like 1, Estrogen resistance, included, Estrogen-related receptor alpha, Estrra, FLJ11090, GCCR, GCRST, GCR_HUMAN, GR, Glucocorticoid receptor, Grl1, HDL cholesterol, augmented response of, to hormone replacement, included, HMDH_HUMAN, HMG CoAR, HMG-CoA reductase, Hydroxymethylglutaryl CoA reductase, ICE-LAP3, ICE-like apoptotic protease 3, ICE3, IMD42, LDLCQ3, LICE, LICE2, Liver-specific organic anion transporter 1, MCH3, MGC103269, MGC104252, MGC112732, MGC129539, MLP 2, MOAT-D, MRP3_HUMAN, Multi-specific organic anion transporter D, Multidrug resistance associated protein, Multidrug resistance-associated protein 3, Multispecific organic anion tranporter D, Myocardial infarction, susceptibility to, included, NF-E2-related factor 2, NF2L2_HUMAN, NR1F3, NR1I2_HUMAN, NR3A1, NR3A2, NR3B1, NRF2, Nfe2l2, Nuclear factor, Nuclear factor (erythroid derived 2) like 2, Nuclear factor erythroid 2-related factor 2, Nuclear factor erythroid derived 2 like 2, Nuclear receptor ROR-gamma, Nuclear receptor RZR-gamma, Nuclear receptor subfamily 1 group F member 3, Nuclear receptor subfamily 1 group I member 2, Nuclear receptor subfamily 3 group A member 1, Nuclear receptor subfamily 3 group A member 2, Nuclear receptor subfamily 3 group B member 1, Nuclear receptor subfamily 3 group C member 1, OATP-2, OATP-C, ONR 1, OTTHUMP00000017718, OTTHUMP00000017719, OTTHUMP00000165052, OTTHUMP00000165053, OTTHUMP00000165054, OTTHUMP00000215173, OTTHUMP00000215174, OTTHUMP00000215175, Orphan nuclear receptor PAR 1, Orphan nuclear receptor PXR, PAR, PAR q, PARP cleavage protease, PFIC 2, PGY4, PRR, Pregnane X receptor, Procaspase3, Protein Yama, RAR related orphan nuclear receptor variant 2, RAR related orphan receptor C, isoform a, RAR related orphan receptor gamma, RAR-related orphan receptor C, RNESTROR, RORG_HUMAN, RP24-311F12.2, RZR GAMMA, RZRG, Retinoic acid binding receptor gamma, Retinoid-related orphan receptor-gamma, Rorc, SCA-1, SCAN1, SLC21A6, SLCO1B1, SO1B1_HUMAN, SREBP cleavage activity 1, SXR, Sister of P glycoprotein, Sodium-independent organic anion-transporting polypeptide 2, Solute carrier family 21 member 6, Solute carrier organic anion transporter family member 1B1, Spgp, Steroid and xenobiotic receptor, Steroid hormone receptor ERR1, TOR, TYDP, TYDP1_HUMAN, Tyr-DNA phosphodiesterase 1, Tyrosyl-DNA phosphodiesterase 1, Yama, Yama protein, erythroid derived 2, estrogen receptor related receptor alpha, glucocorticoid nuclear receptor variant 1, hERR1, like 2, mldy, nr3c1, nuclear factor erythroid 2 like 2, nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor), pregnane X nuclear receptor variant 2, progressive familial intrahepatic cholestasis 2

2 Images
Immunocytochemistry/ Immunofluorescence - Atorvastatin hemicalcium salt, HMG-CoA reductase inhibitor (AB141083)
  • ICC/IF

Unknown

Immunocytochemistry/ Immunofluorescence - Atorvastatin hemicalcium salt, HMG-CoA reductase inhibitor (AB141083)

ab90529 staining cytochrome C in HepG2 cells treated with atorvastatin hemicalcium salt (ab141083), by ICC/IF. Increase of cytochrome C expression correlates with increased concentration of atorvastatin hemicalcium salt, as described in literature.
The cells were incubated at 37°C for 4 hours in media containing different concentrations of ab141083 (atorvastatin hemicalcium salt) in DMSO, fixed with 4% formaldehyde for 10 minutes at room temperature and blocked with PBS containing 10% goat serum, 0.3 M glycine, 1% BSA and 0.1% tween for 2h at room temperature. Staining of the treated cells with ab90529 (1 µg/ml) was performed overnight at 4°C in PBS containing 1% BSA and 0.1% tween. A DyLight 488 anti-rabbit polyclonal antibody (ab96899) at 1/250 dilution was used as the secondary antibody. Nuclei were counterstained with DAPI and are shown in blue.

Chemical Structure - Atorvastatin hemicalcium salt, HMG-CoA reductase inhibitor (AB141083)
  • Chemical Structure

Lab

Chemical Structure - Atorvastatin hemicalcium salt, HMG-CoA reductase inhibitor (AB141083)

2D chemical structure image of ab141083, Atorvastatin hemicalcium salt, HMG-CoA reductase inhibitor

Key facts

CAS number

134523-03-8

Purity

>99%

Form

Solid

form

Molecular weight

1155.3 Da

Molecular formula

C<sub>6</sub><sub>6</sub>H<sub>6</sub><sub>8</sub>CaF<sub>2</sub>N<sub>4</sub>O<sub>1</sub><sub>0</sub>

PubChem

60822

Nature

Synthetic

Solubility

Soluble in DMSO to 100 mM

Biochemical name

Atorvastatin calcium

Biological description

Potent HMG-CoA reductase inhibitor (IC50 = 8 nM). Metabolised by CYP3A4. Able to reduce circulating LDL-C through inhibition of cholesterol biosynthesis and inducing expression of LDL receptors.

Canonical smiles

CC(C)C1=C(C(=C(N1CCC(CC(CC(=O)[O-])O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4.CC(C)C1=C(C(=C(N1CCC(CC(CC(=O)[O-])O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4.[Ca+2]

Isomeric smiles

CC(C)C1=C(C(=C(N1CC[C@H](C[C@H](CC(=O)[O-])O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4.CC(C)C1=C(C(=C(N1CC[C@H](C[C@H](CC(=O)[O-])O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4.[Ca+2]

InChi

InChI=1S/2C33H35FN2O5.Ca/c2*1-21(2)31-30(33(41)35-25-11-7-4-8-12-25)29(22-9-5-3-6-10-22)32(23-13-15-24(34)16-14-23)36(31)18-17-26(37)19-27(38)20-28(39)40;/h2*3-16,21,26-27,37-38H,17-20H2,1-2H3,(H,35,41)(H,39,40);/q;;+2/p-2/t2*26-,27-;/m11./s1

InChiKey

FQCKMBLVYCEXJB-MNSAWQCASA-L

IUPAC Name

calcium;(3R,5R)-7-[2-(4-fluorophenyl)-3-phenyl-4-(phenylcarbamoyl)-5-propan-2-ylpyrrol-1-yl]-3,5-dihydroxyheptanoate

Properties and storage information

Shipped at conditions
Ambient - Can Ship with Ice
Appropriate short-term storage conditions
-20°C
Appropriate long-term storage conditions
-20°C
Storage information
It is important to note that this product is reported to be light sensitive|Store in the dark|Store under desiccating conditions

Product protocols

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com